锝-99m（Tc-）标记化合物用于心肌灌注显像时洗脱现象的临床意义
Clinical Implications of the Washout Phenomenon in Technetium-99m (Tc-) Labeled Compounds for Myocardial Perfusion Imaging.
作者信息
Taniguchi Yasuyo
机构信息
Department of General Medicine, Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center, Hyogo, Japan.
出版信息
Ann Nucl Cardiol. 2024;10(1):55-58. doi: 10.17996/anc.24-00010. Epub 2024 Oct 31.
Abstract
The technetium (Tc) labeled myocardial perfusion compounds are tracers that have been taken up into myocytes and retained in mitochondria several times, thus reflecting the activity of myocytes at the time of injection. However, under certain conditions, "reversed redistribution" is known to occur. This review summarized the unique properties of imaging with the Tc myocardial perfusion tracers.
摘要
锝（Tc）标记的心肌灌注化合物是已被心肌细胞摄取并多次保留在线粒体中的示踪剂，从而反映注射时心肌细胞的活性。然而，在某些情况下，已知会发生“反向再分布”。本综述总结了锝心肌灌注示踪剂成像的独特特性。
相似文献
1
Clinical Implications of the Washout Phenomenon in Technetium-99m (Tc-) Labeled Compounds for Myocardial Perfusion Imaging.锝-99m（Tc-）标记化合物用于心肌灌注显像时洗脱现象的临床意义
Ann Nucl Cardiol. 2024;10(1):55-58. doi: 10.17996/anc.24-00010. Epub 2024 Oct 31.
2
Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.锝-99m 制剂生理特性的实验研究：灌注显像剂的心肌转运
Am J Cardiol. 1990 Oct 16;66(13):9E-15E. doi: 10.1016/0002-9149(90)90606-2.
3
Technetium-99m Radiopharmaceuticals for Ideal Myocardial Perfusion Imaging: Lost and Found Opportunities.锝-99m 放射性药物在理想心肌灌注成像中的应用：失而复得的机遇。
Molecules. 2022 Feb 10;27(4):1188. doi: 10.3390/molecules27041188.
4
Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.使用锝-99m 制剂、铊-201的单光子发射计算机断层扫描（SPECT）与正电子发射断层扫描（PET）在评估心肌灌注和存活能力方面的比较。
Am J Cardiol. 1990 Oct 16;66(13):72E-79E. doi: 10.1016/0002-9149(90)90616-9.
5
Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
Cardiol Rev. 2001 May-Jun;9(3):160-72. doi: 10.1097/00045415-200105000-00009.
6
Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.在犬冠状动脉狭窄模型中，血管扩张剂负荷试验期间注射锝-99m N-DBODC5后的器官生物分布、心肌摄取、洗脱及再分布动力学。
J Nucl Cardiol. 2006 Nov;13(6):779-90. doi: 10.1016/j.nuclcard.2006.08.016.
7
Impact of accelerated washout of Technetium-99m-sestamibi on exercise tolerance in patients with acute coronary syndrome: single-center experience.锝 99m-甲氧基异丁基异腈洗脱加速对急性冠状动脉综合征患者运动耐量的影响：单中心经验。
Heart Vessels. 2022 Sep;37(9):1506-1515. doi: 10.1007/s00380-022-02058-3. Epub 2022 Mar 27.
8
[Myocardial perfusion imaging with [(99m)Tc (N) (PNP5) (DBODC)](+) in canine model of acute myocardial ischemia].[(99m)Tc (N) (PNP5) (DBODC)](+) 在犬急性心肌缺血模型中的心肌灌注显像
Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Oct;35(10):949-55.
9
Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease.
Am J Cardiol. 1993 Nov 1;72(14):1015-9. doi: 10.1016/0002-9149(93)90855-7.
10
Myocardial perfusion imaging with technetium-99m-labeled agents.
Am J Cardiol. 1991 May 21;67(14):27D-34D. doi: 10.1016/s0002-9149(05)80005-0.
本文引用的文献
1
The Utility of a Combination of Tc-MIBI Washout Imaging and Cardiac Magnetic Resonance Imaging in the Evaluation of Cardiomyopathy.锝-甲氧基异丁基异腈洗脱显像与心脏磁共振成像联合应用在心肌病评估中的效用
Ann Nucl Cardiol. 2021;7(1):8-16. doi: 10.17996/anc.21-00124. Epub 2021 Aug 31.
2
Impact of accelerated washout of Technetium-99m-sestamibi on exercise tolerance in patients with acute coronary syndrome: single-center experience.锝 99m-甲氧基异丁基异腈洗脱加速对急性冠状动脉综合征患者运动耐量的影响：单中心经验。
Heart Vessels. 2022 Sep;37(9):1506-1515. doi: 10.1007/s00380-022-02058-3. Epub 2022 Mar 27.
3
Efficacy of myocardial washout of Tc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with F-fluorodeoxyglucose positron emission tomography findings.锝-甲氧基异丁基异腈/替曲膦心肌清除率对心脏结节病患者炎症评估的效能：与氟-氟脱氧葡萄糖正电子发射断层扫描结果的比较
Ann Nucl Med. 2022 Jun;36(6):544-552. doi: 10.1007/s12149-022-01735-7. Epub 2022 Mar 18.
4
Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature.通过缩短注射到成像时间实现的硫代苹果酸锝和甲氧基异丁基异腈的效率：文献的系统评价。
J Nucl Cardiol. 2021 Aug;28(4):1381-1394. doi: 10.1007/s12350-020-02093-5. Epub 2020 Mar 31.
5
(99m)Tc-MIBI Washout Rate to Evaluate the Effects of Steroid Therapy in Cardiac Sarcoidosis.利用（99m）Tc-MIBI洗脱率评估类固醇疗法对心脏结节病的疗效
Asia Ocean J Nucl Med Biol. 2013 Fall;1(2):4-9.
6
Deterioration of cardiac function during the progression of cardiac sarcoidosis: diagnosis and treatment.
Intern Med. 2014;53(15):1595-605. doi: 10.2169/internalmedicine.53.2784. Epub 2014 Aug 1.
7
Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI.99mTc-司他米比心肌显像中的反向灌注模式。
J Med Life. 2013 Sep 15;6(3):349-54. Epub 2013 Sep 25.
8
Measuring mitochondrial function in intact cardiac myocytes.测定完整心肌细胞中的线粒体功能。
J Mol Cell Cardiol. 2012 Jan;52(1):48-61. doi: 10.1016/j.yjmcc.2011.08.030. Epub 2011 Sep 22.
9
Myocardial washout rate of technetium-99m-sestamibi in the chronic phase predicts myocardial damage in patients with previous myocardial infarction.锝-99m 甲氧基异丁基异腈在慢性期的洗脱率可预测既往心肌梗死患者的心肌损伤。
Ann Nucl Med. 2011 Dec;25(10):740-8. doi: 10.1007/s12149-011-0519-6. Epub 2011 Jul 28.
10
Myocardial washout of 99mTc-tetrofosmin and response to steroid therapy in patients with cardiac sarcoidosis.心肌 99mTc-替曲膦洗脱与心脏结节病患者激素治疗反应。
Ann Nucl Med. 2010 Jun;24(5):379-85. doi: 10.1007/s12149-010-0376-8. Epub 2010 May 8.
Zotero 插件